
Loading, please wait...

Loading, please wait...

A Cochrane review evaluated interventions intended to improve inhaler technique in people with asthma. The evidence base included educational approaches delivered by health professionals and other structured methods designed to correct device-use errors. Across studies, training could improve inhaler technique compared with usual care, although the certainty of evidence and durability of benefit varied. The review also highlights an important practical limitation: improving technique is not the same as proving a reduction in exacerbations, hospitalizations or other hard outcomes, because many trials were small or short and used different measures of technique. For clinicians, the message is still highly actionable. Poor technique is a modifiable contributor to ineffective inhaled therapy, so technique should be checked directly rather than assumed from a prescription history. Teach-back, demonstration and repeat assessment are more reliable than asking whether the patient “knows how” to use the device. This aligns closely with NAPCON's emphasis on inhaler technique before step-up therapy. The publication supports embedding device review into routine asthma follow-up, particularly when symptoms remain uncontrolled despite apparently appropriate treatment.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A Cochrane review evaluated interventions intended to improve inhaler technique in people with asthma. The evidence base included educational approaches delivered by health professionals and other structured methods designed to correct device-use errors. Across studies, training could improve inhaler technique compared with usual care, although the certainty of evidence and durability of benefit varied. The review also highlights an important practical limitation: improving technique is not the same as proving a reduction in exacerbations, hospitalizations or other hard outcomes, because many trials were small or short and used different measures of technique. For clinicians, the message is still highly actionable. Poor technique is a modifiable contributor to ineffective inhaled therapy, so technique should be checked directly rather than assumed from a prescription history. Teach-back, demonstration and repeat assessment are more reliable than asking whether the patient “knows how” to use the device. This aligns closely with NAPCON's emphasis on inhaler technique before step-up therapy. The publication supports embedding device review into routine asthma follow-up, particularly when symptoms remain uncontrolled despite apparently appropriate treatment.
3 weeks back

Discover how catalytic nanozymes redefine autoimmune disease therapy by establishing a physiological redox set-point to restore immune tolerance without broad immunosuppression.
Last week

Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
3 weeks back

A landmark comparative study evaluates atrial electrophysiology across humans, swine, and rodents. By linking cellular recordings with transcriptomics and in silico modeling, researchers resolve cross-species gaps, explaining translational failures to advance targeted therapies for atrial arrhythmias.
3 weeks back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
last month

Researchers have developed an innovative ultrasound-responsive nano-contrast agent that co-delivers CIITA-siRNA and rapamycin directly to inflamed thyroid tissue, significantly reducing autoimmune injury and thyroid autoantibodies in preclinical models of Hashimoto thyroiditis.
3 weeks back